For IL5RA, Fan et al. reported its potential as a predictor of prognosis and immunotherapy response in lung cancer, and Martin et al. showed its upregulation in drug-resistant Hodgkin lymphoma cells14,15. Here, IL5RA is linked to lung carcinoma.